AbbVie Inc. (ABBV) Shares Sold by HighVista Strategies LLC

Sabal Trust Co increased Abbvie Inc (ABBV) stake by 2.3% reported in 2017Q2 SEC filing. Abner Herrman & Brock LLC now owns 6,293 shares of the company's stock worth $456,000 after acquiring an additional 18 shares during the last quarter.

Glenmede Trust Company Na increased F5 Networks Inc (FFIV) stake by 1.17% reported in 2017Q2 SEC filing. Abbvie Inc now has $153.18 billion valuation. State Street Corp now owns 72,969,530 shares of the company's stock worth $4,754,696,000 after purchasing an additional 1,696,042 shares during the last quarter. 5,176,356 shares of the company were exchanged, compared to its average volume of 4,280,968. The original version of this article can be read at https://www.thelincolnianonline.com/2017/12/10/doliver-capital-advisors-lp-invests-775000-in-abbvie-inc-abbv-stock.html. It has underperformed by 6.07% the S&P500. Seven equities research analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has issued a strong buy rating to the company. Therefore 100% are positive. Abbvie Inc had 69 analyst reports since July 21, 2015 according to SRatingsIntel. Invest Management Of Virginia Llc, Virginia-based fund reported 93,949 shares. Also, CFO William J. Chase sold 38,300 shares of the stock in a transaction dated Thursday, May 18th. The rating was initiated by Standpoint Research with "Buy" on Wednesday, August 26. Citigroup maintained the shares of TAST in report on Monday, November 20 with "Buy" rating. On Thursday, July 27 the stock rating was maintained by Robert W. Baird with "Hold". (NYSE:ABBV). Greenleaf has invested 0.06% in AbbVie Inc. Barclays reaffirmed a "hold" rating and set a $68.00 price target on shares of AbbVie in a research report on Thursday, September 28th. The rating was downgraded by Goldman Sachs to "Buy" on Monday, March 7.

Investors sentiment decreased to 0.96 in Q2 2017. Its down 0.06, from 0.92 in 2017Q1. 124 funds opened positions while 388 raised stakes. Jefferies Group LLC reiterated a "buy" rating and issued a $90.00 price objective (up previously from $4.30) on shares of AbbVie in a report on Tuesday, March 7th. Prudential Financial Inc. now owns 5,469,241 shares of the company's stock worth $396,575,000 after buying an additional 1,603,748 shares during the period. Insiders own 0.23% of the company's stock. At Bank & Trust stated it has 0.14% in The Boeing Company (NYSE:BA). About 1.32 million shares traded. Financial Architects reported 3,779 shares or 0.13% of all its holdings. Finally, BMO Capital Markets reissued a "hold" rating and set a $84.00 target price on shares of AbbVie in a research report on Tuesday, November 21st. During the same quarter in the previous year, the firm posted $1.15 EPS. Loeb Partners Corp invested in 0.33% or 15,630 shares. Patten & Patten Tn stated it has 193,731 shares. Hudock Cap Gp Ltd invested in 0.06% or 1,542 shares. Tradition Limited Liability Company has invested 1.87% in The Boeing Company (NYSE:BA). Horizon Kinetics Ltd Com has 0.08% invested in AbbVie Inc. 9,935 were reported by Pittenger And Anderson. Tompkins Financial Corporation, New York-based fund reported 383 shares.

Greenhaven Associates Inc increased D R Horton Inc. The institutional investor held 574,091 shares of the major pharmaceuticals company at the end of 2017Q2, valued at $41.63 million, down from 1.44M at the end of the previous reported quarter. Rathbone Brothers Public Limited Com stated it has 106,567 shares. Schwab Us Large Cap (SCHG) was raised too. (NASDAQ:CA) to report earnings on January, 23. Baker Avenue Asset Mngmt Limited Partnership invested in 0.15% or 16,008 shares. The company reported $1.28 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $1.26 by $0.02. Capital Research Global Investors lifted its stake in shares of AbbVie by 1.2% in the 2nd quarter. Its up 0.01, from 0.99 in 2017Q1.

Swiss National Bank raised its position in shares of AbbVie Inc. Alpha Windward Limited Com accumulated 9,762 shares. Eqis Capital Mgmt Incorporated holds 24,530 shares. Edgewood Mgmt Limited Liability holds 0.03% or 83,687 shares. 59,210 were accumulated by Jacobus Wealth Mngmt Inc. (NYSE:ABBV). Northstar Inv Advisors Limited Liability Company stated it has 12,643 shares. Moreover, Ar Asset Management has 0.36% invested in AbbVie Inc. Vanguard Group Inc. increased its position in AbbVie by 3.3% during the second quarter. (NYSE:ABBV) or 1,673 shares.

Among 21 analysts covering Abbvie Inc (NYSE:ABBV), 11 have Buy rating, 1 Sell and 9 Hold.

Hosts Al Jazira beat Urawa Red Diamonds to reach semis
The first semi-final takes place on Tuesday in Al Ain as Gremio go up against Pachuca. "We were really looking forward to getting here".

AbbVie (NYSE:ABBV) last issued its quarterly earnings results on Thursday, April 27th. Cadence Cap Limited Liability Com invested in 182,039 shares. Amalgamated Bancorp has 7,608 shares for 0.03% of their portfolio. BlackRock Inc. increased its position in AbbVie by 2.0% during the second quarter.

AbbVie (NYSE:ABBV) last issued its earnings results on Friday, October 27th. Therefore 52% are positive.

AbbVie Inc (AbbVie) is a research-based biopharmaceutical company.

In related news, SVP Azita Saleki-Gerhardt sold 8,300 shares of the company's stock in a transaction on Monday, September 11th. Finally, ValuEngine downgraded AbbVie from a "strong-buy" rating to a "buy" rating in a research note on Friday, December 1st. The stock has "Outperform" rating by Raymond James on Friday, September 2. The stock has "Neutral" rating by Citigroup on Monday, November 28. The rating was maintained by Leerink Swann with "Outperform" on Monday, October 30. $5.59 million worth of AbbVie Inc. The firm has "Hold" rating by BMO Capital Markets given on Friday, April 28. As per Friday, July 28, the company rating was maintained by Cowen & Co. On Tuesday, October 18 the stock rating was initiated by Leerink Swann with "Mkt Perform".

Destination Wealth Management decreased Apple Inc (NASDAQ:AAPL) stake by 19,937 shares to 302,576 valued at $43.58M in 2017Q2.

Several other research analysts have also recently weighed in on the company.

Latest News